3-193402838-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_032279.4(ATP13A4):c.3405G>A(p.Leu1135Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00262 in 1,614,038 control chromosomes in the GnomAD database, including 89 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.014 ( 46 hom., cov: 32)
Exomes 𝑓: 0.0014 ( 43 hom. )
Consequence
ATP13A4
NM_032279.4 synonymous
NM_032279.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.582
Genes affected
ATP13A4 (HGNC:25422): (ATPase 13A4) Predicted to enable ATPase-coupled cation transmembrane transporter activity. Predicted to be involved in cellular calcium ion homeostasis. Predicted to be located in endoplasmic reticulum membrane and endosome membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.49).
BP6
Variant 3-193402838-C-T is Benign according to our data. Variant chr3-193402838-C-T is described in ClinVar as [Benign]. Clinvar id is 787264.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.582 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0142 (2160/152232) while in subpopulation AFR AF= 0.0503 (2089/41520). AF 95% confidence interval is 0.0485. There are 46 homozygotes in gnomad4. There are 1001 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 46 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATP13A4 | NM_032279.4 | c.3405G>A | p.Leu1135Leu | synonymous_variant | 30/30 | ENST00000342695.9 | NP_115655.2 | |
ATP13A4 | XM_047449063.1 | c.3534G>A | p.Leu1178Leu | synonymous_variant | 32/32 | XP_047305019.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATP13A4 | ENST00000342695.9 | c.3405G>A | p.Leu1135Leu | synonymous_variant | 30/30 | 1 | NM_032279.4 | ENSP00000339182.4 |
Frequencies
GnomAD3 genomes AF: 0.0142 AC: 2157AN: 152114Hom.: 46 Cov.: 32
GnomAD3 genomes
AF:
AC:
2157
AN:
152114
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00347 AC: 871AN: 250890Hom.: 19 AF XY: 0.00258 AC XY: 350AN XY: 135650
GnomAD3 exomes
AF:
AC:
871
AN:
250890
Hom.:
AF XY:
AC XY:
350
AN XY:
135650
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00141 AC: 2066AN: 1461806Hom.: 43 Cov.: 31 AF XY: 0.00119 AC XY: 865AN XY: 727202
GnomAD4 exome
AF:
AC:
2066
AN:
1461806
Hom.:
Cov.:
31
AF XY:
AC XY:
865
AN XY:
727202
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0142 AC: 2160AN: 152232Hom.: 46 Cov.: 32 AF XY: 0.0134 AC XY: 1001AN XY: 74434
GnomAD4 genome
AF:
AC:
2160
AN:
152232
Hom.:
Cov.:
32
AF XY:
AC XY:
1001
AN XY:
74434
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
15
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at